Virginia J. Bruce, Brian R. McNaughton  Cell Chemical Biology 

Slides:



Advertisements
Similar presentations
Protein Shell DNA or RNA Membrane around virus Proteins that help virus get into proper host.
Advertisements

Viruses of Bacteria Chapter 13. General Characteristics of Viruses Non-living entities Not considered organisms Can infect organisms of every domain All.
 Non-living entities  Can infect organisms of every domain  Commonly referred to by organism they infect  Viruses that infect bacteria: Bacteriophage.
Viruses, part 2.
Trends in Biotechnology TB 14 Microinjection, stem cell transfer, gene targeting, and use of retroviruses 1.
Viruses as Pathogens Viruses are obligate intracellular pathogens. – They are not living and cannot metabolize to create energy. – They cannot reproduce.
NIS - BIOLOGY Lecture 57 – Lecture 58 DNA Technology Ozgur Unal 1.
What … have genetic material and can mutate and evolve, can not metabolize food, can not respond to stimuli, are not made up of cells, can only reproduce.
Viruses are the smallest infectious diseases (ranging from nm) They are obligatory intracellular parasites without own metabolism (being parasites.
The Viruses January 14 th, Virus Basics Viruses are nucleic acid and protein structures Very small; typically between nm No cellular structures.
Viruses. Biology of Viruses Structure of Viruses: Size -Less then 0.2 microns Parts of the Virus 1)Capsid: -Made of protein subunits 2) Inner core: made.
PHARMACOBIOTECHNOLOGY.  Recombinant DNA (rDNA) is constructed outside the living cell using enzymes called “restriction enzymes” to cut DNA at specific.
Lecture-7 Genome editing CRISPR
Viral and Bacterial Genomes & DNA Technology. Viruses Tiny; much smaller than a bacteria Basic structure: – Nucleic acid (DNA or RNA) enclosed in a protein.
Virology Prof. Dr. Kareem Thamir Al-Kaabi. Objectives of the lecture The main objective of the present lecture is to understand the important chemical.
Gene therapy.
Viruses Page 328.
Jean Dubuisson, François-Loïc Cosset  Journal of Hepatology 
Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer  Behrad Darvishi, Leila Farahmand,
Viruses.
Virology Introduction Viral Structure Bacteriophage Replication
Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer  Behrad Darvishi, Leila Farahmand,
Expanding the Biologist’s Toolkit with CRISPR-Cas9
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Rewiring Cas9 to Target New PAM Sequences
Figure 2 Use of CRISPR/Cas9 for genome editing
Jiehua Zhou, John J. Rossi  Molecular Therapy - Nucleic Acids 
Genome editing by CRISPR
Harnessing CRISPR–Cas systems for bacterial genome editing
Packaged Genes – “Ready for Delivery”
Unit 2 – Biodiversity - Virus
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Addison V. Wright, James K. Nuñez, Jennifer A. Doudna  Cell 
The CRISPR/Cas9 system.1 Clustered regularly interspaced palindromic repeats (CRISPR) refers to sequences in the bacterial genome. The CRISPR/Cas9 system.1.
Research Techniques Made Simple: The Application of CRISPR-Cas9 and Genome Editing in Investigative Dermatology  Joan Ramon Guitart, Jodi L. Johnson,
Mouse Genome Engineering via CRISPR-Cas9 for Study of Immune Function
Volume 65, Issue 1, Pages (January 2017)
Figure 1 Adaptive immune system of bacteria and archaea
Molecular Therapy - Nucleic Acids
Bioactive Cell-Penetrating Peptides: Kill Two Birds with One Stone
CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
Therapeutic editing of hepatocyte genome in vivo
USH2A Gene Editing Using the CRISPR System
RNA-DNA Triplex Formation by Long Noncoding RNAs
The CRISPR/Cas9 system.1 Clustered regularly interspaced palindromic repeats (CRISPR) refers to sequences in the bacterial genome. The CRISPR/Cas9 system.1.
Joseph Bondy-Denomy, Alan R. Davidson  Trends in Microbiology 
CRISPR genome-editing: A medical revolution
Volume 164, Issue 1, Pages (January 2016)
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
RNA bulges as architectural and recognition motifs
Advances in Industrial Biotechnology Using CRISPR-Cas Systems
Knocking down Disease with siRNAs
A CRISPR Approach to Gene Targeting
William T. Hendriks, Curtis R. Warren, Chad A. Cowan  Cell Stem Cell 
Ignazio Maggio, Manuel A.F.V. Gonçalves  Trends in Biotechnology 
Positive Reinforcement for Viruses
Jean Dubuisson, François-Loïc Cosset  Journal of Hepatology 
Viruses Page 328.
Viruses Page 328.
Ciaran M Lee, Thomas J Cradick, Gang Bao  Molecular Therapy 
Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence replacement. Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence.
CRISPR/Cas9: Transcending the Reality of Genome Editing
A Protein Transduction Domain with Cell Uptake and Selectivity Profiles that Are Controlled by Multivalency Effects  Sandra M. DePorter, Irene Lui, Utpal.
The Biology of CRISPR-Cas: Backward and Forward
Chemical Biology Approaches to Genome Editing: Understanding, Controlling, and Delivering Programmable Nucleases  Johnny H. Hu, Kevin M. Davis, David R.
Simon Wisnovsky, Eric K. Lei, Sae Rin Jean, Shana O. Kelley 
Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off- target Effects in Genome Editing  Ciaran M Lee, Thomas J Cradick,
Jiehua Zhou, John J. Rossi  Molecular Therapy - Nucleic Acids 
Hildegard Büning, Arun Srivastava 
Presentation transcript:

Inside Job: Methods for Delivering Proteins to the Interior of Mammalian Cells  Virginia J. Bruce, Brian R. McNaughton  Cell Chemical Biology  Volume 24, Issue 8, Pages 924-934 (August 2017) DOI: 10.1016/j.chembiol.2017.06.014 Copyright © 2017 Terms and Conditions

Figure 1 Common Approaches for Achieving Intracellular Delivery of Protein-Encoding Nucleic Acids (A) DNA/lipid-cation assemblies. (B) Viral vectors with encapsulated DNA. (C) Lipid bilayer deformation/physical insertion. Cell Chemical Biology 2017 24, 924-934DOI: (10.1016/j.chembiol.2017.06.014) Copyright © 2017 Terms and Conditions

Figure 2 Cell-Selective Cell-Penetrating Peptides (A) Cell-selective delivery of protein cargo to cancer cells with cancer cell-activated cell-penetrating peptides (CPPs). Cell entry with a polycationic CPP is suppressed with a linked polyanionic sequence. However, when the polyanionic peptide is cleaved from the polycationic peptide, by an oncogenic matrix metalloprotease present in serum, the polycationic cell-penetrating peptide-protein cargo fusion enters neighboring (cancerous) cells. (B) Phage display selection for new cell-selective CPPs. A peptide phage display library is incubated with healthy cells and phage that do not penetrate these cells are enriched. Enriched phage are then incubated with diseased cells, and phage that penetrate these cells—by virtue of the phage-displayed peptide—are enriched. Cell Chemical Biology 2017 24, 924-934DOI: (10.1016/j.chembiol.2017.06.014) Copyright © 2017 Terms and Conditions

Figure 3 Polycationic Resurfaced Proteins Can Potently Penetrate the Lipid Bilayer of Mammalian Cells Representative examples include (A) arginine grafted GFP, (B) supercharged GFP, and (C) polycationic resurfaced nanobodies. Mutated residues are highlighted as spheres (arginine, purple; lysine, blue). Nanobody complementary determining regions are highlighted in orange. Cell Chemical Biology 2017 24, 924-934DOI: (10.1016/j.chembiol.2017.06.014) Copyright © 2017 Terms and Conditions

Figure 4 Cellular Delivery by Toxin-Derived Proteins B-type protein PA is recognized by a cell surface receptor (A). Following multimeric assembly of PA, (B) LFN (genetically fused to a cargo protein) is delivered, and recognized by the PA assembly. Following (C) endocytosis, PA (D) creates pores in the endosome membrane, leading to (E) translocation of LFN fusion through the PA assembly to enable cytosolic delivery of the cargo protein. Cell Chemical Biology 2017 24, 924-934DOI: (10.1016/j.chembiol.2017.06.014) Copyright © 2017 Terms and Conditions

Figure 5 Phage- and Nanoparticle-Based Approaches to Protein Delivery (A) Engineered bacteriophage for delivery of exogenous proteins to prostate cancer cells. Phage are evolved to display a prostate cancer cell-selective CPP on the terminus of p3, and a biotin ligase receptor peptide on p9. Following biotinylation, phage are incubated with streptavidin (Sav) protein fusion, and incubated with cells. (B) Cationic capped gold nanoparticles are incubated with a polyanionic protein, such as β-galactosidase, to form a nanocomplex. Once formed this complex is taken up by mammalian cells, resulting in functional protein delivery. Cell Chemical Biology 2017 24, 924-934DOI: (10.1016/j.chembiol.2017.06.014) Copyright © 2017 Terms and Conditions

Figure 6 Delivery of CRISPR Protein-RNA Complexes to Mammalian Cells (A) CRISPR technology consists of the Cas9 endonuclease protein (light blue), complexed to a single guide RNA (sgRNA, orange); this engages genomic DNA (black) in a sequence-defined manner, based on the dictates of DNA:RNA duplex formation. Cas9 then makes a double-stranded break in genomic DNA, flanked by a protospacer adjacent motif (pam, white). The double-stranded break can be reconnected by non-homologous end joining or by homology-directed repair, using an exogenous piece of double-stranded DNA (dsDNA, purple). (B) The Cas9:sgRNA complex has a high theoretical negative charge. When pre-complexed with cationic lipids, delivery to the interior of mammalian cells is achieved. Cell Chemical Biology 2017 24, 924-934DOI: (10.1016/j.chembiol.2017.06.014) Copyright © 2017 Terms and Conditions